scroll to top
0
Your source for trusted research content

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "non-vitamin-K antagonist oral anticoagulants"

Filter
1 - 10 of 500 results for
 "non-vitamin-K antagonist oral anticoagulants"
Sort By:
Your filters
  • Filter by:
  • Reset filters

    • Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis

    Publication Type: Academic Journal

    Source(s): Frontiers in Pharmacology, Vol 14 (2023)

    Abstract: Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial. We performed a ...

    Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus

    Publication Type: Academic Journal

    Source(s): Reviews in Cardiovascular Medicine, Vol 24, Iss 3, p 74 (2023)

    Abstract: Background: To describe the characteristics, treatment practices, and clinical outcomes of patients with ventricular mural thrombus (VMT), with emphasis on the comparison of non-vitamin K antagonist oral anticoagulants (NOACs) and vitamin K antagonists...

    Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device

    Publication Type: Academic Journal

    Source(s): Journal of the Formosan Medical Association, Vol 121, Iss 8, Pp 1488-1494 (2022)

    Abstract: Background/Purpose: Anticoagulant therapy is suggested within 45 days after Watchman device implantation for stroke prevention in patients with atrial fibrillation (AF). A previous study demonstrated that non-vitamin K antagonist oral anticoagulants (N...

    Managing thrombotic risk in patients with diabetes

    Publication Type: Academic Journal

    Source(s): Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-16 (2022)

    Abstract: Abstract It is well known that diabetes is a prominent risk factor for cardiovascular (CV) events. The level of CV risk depends on the type and duration of diabetes, age and additional co-morbidities. Diabetes is an independent risk factor for atrial f...

    Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study

    Publication Type: Academic Journal

    Source(s): BMC Primary Care, Vol 23, Iss 1, Pp 1-13 (2022)

    Abstract: Abstract Background To assess baseline characteristics, drug utilisation and healthcare use for oral anticoagulants (OACs) following the introduction of non-vitamin K antagonist oral anticoagulants among patients with atrial fibrillation in primary car...

    Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis

    Publication Type: Academic Journal

    Source(s): Frontiers in Cardiovascular Medicine, Vol 9 (2022)

    Abstract: BackgroundNon-vitamin K antagonist oral anticoagulants (NOACs) showed a benefit-risk profile superior to that of warfarin in atrial fibrillation (AF) patients with mild to moderate chronic kidney disease. However, the effectiveness and safety of NOACs ...

    Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain

    Publication Type: Academic Journal

    Source(s): Journal of Clinical Medicine, Vol 12, Iss 1224, p 1224 (2023)

    Abstract: Non-vitamin K antagonist oral anticoagulants (NOACs) have substantially improved anticoagulation. However, data on NOAC use among elderly patients are scarce. We sought to describe NOAC use among elderly AF patients in Spain. We performed a non-interve...

    Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

    Publication Type: Academic Journal

    Source(s): International Journal of Arrhythmia, Vol 23, Iss 1, Pp 1-8 (2022)

    Abstract: Abstract Background Non-vitamin K antagonist oral anticoagulants (NOACs) are preferred over vitamin K antagonists (VKAs) as oral anticoagulant (OAC) therapy in patients with nonvalvular atrial fibrillation (NVAF). This study aimed to estimate the curre...

    Prevalence, risk factors, and prediction of inappropriate use of non-vitamin K antagonist oral anticoagulants in elderly Chinese patients with atrial fibrillation: A study protocol

    Publication Type: Academic Journal

    Source(s): Frontiers in Cardiovascular Medicine, Vol 9 (2022)

    Abstract: BackgroundAtrial fibrillation (AF) is an arrhythmia that is prevalent globally, and its incidence grows exponentially with aging. Non-vitamin K antagonist oral anticoagulants (NOACs) have been developed in recent years, and it challenges the supremacy ...

    Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants

    Publication Type: Academic Journal

    Source(s): International Journal of Cardiology: Heart & Vasculature, Vol 40, Iss , Pp 101009- (2022)

    Abstract: Background: Patients with non-valvular atrial fibrillation (NVAF) need prophylactically antithrombotic therapies to reduce the risk of stroke. We hypothesized that the prognostic benefits of prophylactic antithrombotic therapies outweighed the bleeding...

    sponsored